hotspot -WSS

hotspot

author：leisure time 2025-09-07 11:09:36 - browse：89538

JOSEPH PREZIOSO/AFP via Getty Images

LONDON — The U.K.’s cost-effectiveness watchdog said Thursday it is not yet recommending Vertex’s CRISPR-based therapy for sickle cell disease, saying in draft guidance it has questions about the medicine’s lasting benefits for patients.

U.K. regulators approved the therapy, known as Casgevy or exa-cel, last year, granting it the world’s first authorization for any CRISPR-based medicine. But observers have been watching to see how the U.K.’s National Institute for Health and Care Excellence, as well as similar agencies in European countries, would view the pricey, one-time therapy. NICE needs to recommend the therapy for it to be offered in the National Health Service.

In the U.S., Casgevy has a list price of $2.2 million. It was developed by Vertex in partnership with CRISPR Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： New research casts further doubt on a common procedure used with IVF

hotspot

WSS

Failure, not just success, should guide future doctors

Study: Pain burden is higher in Black NFL players than white ones

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

How CRISPR works, explained in two minutes

Flash flood warnings continue for parts of Missouri, Illinois

How the political right came to back psychedelics to treat trauma

hotspot

hotspot

explore

Duchenne breakthrough therapy leaves behind pioneering families

With heat waves through August, officials warn of health risks

State Dept. review finds Biden bears some blame for Afghanistan failures

Oak trusses raised to roof of fire

How one medical school became remarkably diverse

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Guidelines to prevent youth baseball injuries need more muscle

Living with Fabry disease, a condition that causes chronic pain

Medicare details structure of new drug price negotiation program

Charles Manson follower Leslie Van Houten released from prison after 53 years

hotspot

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

N.Y. state detects polio case, first in the U.S. since 2013

It's time to get medical device identifiers over the finish line

Flash flood warnings continue for parts of Missouri, Illinois

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

NIH fellows want a pay raise. Will that mean less money for grants?

Wikipedia

knowledge

hotspot

Wikipedia